1. Yang F, Zheng B, and Xu X. Comparison of three kinds of fish growth hormone cDNAs.

Acta Biochimica et Biophysica Sinica. 1995; 27: 537-540.

2. Chen C, Zheng B, Han J, Lin SC. Characterization of novel mammalian RGS protein that
binds to Galpha proteins and inhibits pheromone signaling in yeast. J. Biol. Chem. 1997;
272:8679-85.
3. De Vries L, Lou X., Zhao G., Zheng B and Farquhar MG. GIPC, a novel PDZ domain
containing protein, interacts specifically with the C-terminus of RGS-GAIP. Proc. Natl.
Acad. Sci. USA 1998; 95:12340-12345.
4. Zheng B, De Vries L, and Farquhar MG. Divergence of RGS proteins: Evidence for the
existence of six mammalian RGS subfamilies. Trends Biochem. Sci. 1999; 24:411-414.
5. Zheng B, Chen, D and Farquhar MG. MIR16, a putative membrane glycerophosphodiester
phosphodiesterase, interacts with RGS16. Proc. Natl. Acad. Sci. USA 2000; 97:39994004.
6. Zheng B, Ma Y-C, Ostrom R.S, Lavoie C, Gill G, Insel PA, Huang X-Y, and Farquhar MG.
RGS-PX1, GAP for Gas and a sorting nexin in vesicular trafficking. Science 2001;
294:1939-1942.
7. Derrien A, Zheng B, Osterhout JL, Ma Y-C, Farquhar MG, and Druey KM. Src-mediated
RGS16 tyrosine phosphorylation promotes RGS16 stability. J. Biol. Chem. 2003; 278:
16107-16116.
8. Zheng B, Berrie C, Corda D, and Farquhar MG. GDE1/MIR16 is a Glycerophosphoinositol
Phosphodiesterase Regulated by Stimulation of G Protein-Coupled Receptors. Proc. Natl.
Acad. Sci. USA 2003; 100:1745-1750.
9. Zheng B, Lavoie C, Tang TD, Ma P, Meerloo T, Beas A, and Farquhar MG. Regulation of
EGF Receptor Degradation by Heterotrimeric Galphas Protein. Mol. Biol. Cell. 2004;
15:5538-5550
10. Zheng B, Tang T, Tang N, Kudlicka K, Ohtsubo K, Ma P, Marth JD, Farquhar MG, and
Lehtonen E. Essential role of RGS-PX1/sorting nexin 13 in mouse development and
regulation of endocytosis dynamics. Proc. Natl. Acad. Sci. USA 2006; 103: 16776-81.
11. Asara JM, Zhang X, Zheng B, Christofk HH, Wu N, and Cantley LC. In-Gel Stable-Isotope
Labeling (ISIL): a strategy for mass spectrometry-based relative quantification. J Proteome
Res. 2006; 5:155-63.
12. Asara JM, Zhang X, Zheng B, Maroney LA, Christofk HH, Wu N, and Cantley LC. In-Gel
Stable Isotope Labeling for relative quantification using mass spectrometry. Nature
Protocols. 2006; 1:46-51.
13. Zheng B, and Cantley LC. Regulation of epithelial tight junction assembly and disassembly
by AMP-activated protein kinase. Proc. Natl. Acad. Sci. USA 2007; 104:8-11.
14. Tang T, Zheng B, Chen S, Murphy AN, Kudlicka K., Zhou H and Farquhar MG. hNOA1
Interacts With Complex I and DAP3 and Regulates Mitochondrial Respiration and Apoptosis.
J Biol Chem 2009; 284:5414-24.
15. Zheng B, Jeong JH, Asara JM, Yuan Y, Granter SR, Chin L, and Cantley LC. Oncogenic BRAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell
Proliferation. Molecular Cell 2009; 33, 237-247

16. Amato S, Liu X, Zheng B, Cantley L, Rakic P, and Man HY. AMP-activated protein kinase
regulates neuronal polarization by interfering with PI 3-kinase localization. Science. 2011;
332:247-51.
17. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY,
Gao B, Wierzbicki M, Verbeuren TJ, Shaw RJ, Cohen RA, and Zang M. AMPK
phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis
in diet-induced insulin-resistant mice. Cell Metabolism. 2011; 13:376-88.
18. Tsou P, Zheng B, Hsu CH, Sasaki AT, and Cantley LC. A fluorescent reporter of AMPK
activity and cellular energy stress. Cell Metabolism. 2011; 13:476-86.
19. Mack HID, Zheng B, Asara J, and Thomas SM. AMPK-dependent phosphorylation of
ULK1 regulates ATG9 localization. Authophagy. 2012; 8(8):1197-1214
20. Yang Y, Wu J, Demir A, Castillo-Martin M, Melamed RD, Zhang G, Fukunaga-Kanabis M,
Perez-Lorenzo R, Zheng B, Silvers DN, Brunner G, Wang S, Rabadan R, Cordon-Cardo C,
Celebi JT. GAB2 induces tumor angiogenesis in NRAS-driven melanoma. Oncogene. doi:
2012; 10.1038/onc.2012.367.
21. Dagon Y, Hur E, Zheng B, Wellenstein K, Cantley LC, and Kahn BB. p70S6-kinase
phosphorylates AMPK on serine 491 to mediate leptins effect on food intake. Cell
Metabolism. 2012; 16(1):104-112.
22. Ning W, Zheng B, Shaywitz A, Dagon Y, Tower C, Bellinger G, Shen CH, Asara J, Kahn
B, Cantley JC. AMPK-dependent degradation of TXNIP in response to energy stress results
in enhanced glucose uptake via GLUT1. Molecular Cell 2013. 49:1167-75.
23. Che-Hung Shen, Ping Yuan, Rolando Perez-Lorenzo, Yaqing Zhang, Yang Ou, Sze Xian
Lee, John Asara, Lewis C. Cantley and Bin Zheng. AMPK phosphorylates BRAF to
regulate BRAF-KSR1 association and cell proliferation. Molecular Cell 2013. 52:161-172
24. Koichi Ito, Ping Yuan, Rolando Perez-Lorenzo, Christina Del Guzzo, Jung Hyun Lee, CheHung Shen, Marcus W. Bosenberg, Martin McMahon, Lewis C. Cantley, Bin Zheng.
Phenformin enhances the therapeutic benefit of BRAFV600E inhibition in melanoma. Proc.
Natl. Acad. Sci. USA. Oct 2013. www.pnas.org/cgi/
doi/10.1073/pnas.1317577110
25. Rolando Perez-Lorenzo, Kamraan Z Gill, Che-Hung Shen, Feng Xian Zhao, Bin Zheng,
Hans-Joachim Schulze, David N Silvers, Georg Brunner, Basil A Horst. 2013. A Tumor
Suppressor Function for the Lipid Phosphatase INPP4B in Melanocytic Neoplasms. J. Inv.
Derm. 11/2013; DOI:10.1038/jid.2013.511

Other peer-reviewed publications

1. De Vries L, Zheng B, Fischer T, Elenko E, and Farquhar MG. The Regulator of G Protein
Signaling (RGS) family. Annu. Rev. Pharmacol. & Toxicol. 2000; 40:235-271.
2.

Perez-Lorenzo R., and Zheng B. Targeted inhibition of BRAF kinase: opportunities and
challenges for therapeutics in melanoma. Bioscience Reports. 2012; 32:25-33.